The FDA reversed course and agreed to begin a review of Moderna's seasonal flu shot
Moderna(US:MRNA) WSJ·2026-02-18 22:12公司mRNA流感疫苗研发进展与潜在上市时间 - 公司的mRNA流感疫苗若获得批准，可能于2026-27流感季节上市 [1]
Moderna(US:MRNA) WSJ·2026-02-18 22:12Moderna(US:MRNA) WSJ·2026-02-18 22:12